FGF23 induces left ventricular hypertrophy

Cited by (1,002)

Items 101–200 of 1,002

1. An update on uremic toxins
   Nathalie Neirynck, Raymond Vanholder, Eva Schepers, Sunny Eloot, Anneleen Pletinck, Griet Glorieux · 2012 · International Urology and Nephrology
2. Heart Failure in Patients with Chronic Kidney Disease: A Systematic Integrative Review
   Liviu Segall, Ionuţ Nistor, Adrian Constantin Covic · 2014 · BioMed Research International
3. The PTH-Vitamin D-FGF23 axis
   Jenny E. Blau, Michael Terrence Collins · 2015 · Reviews in Endocrine and Metabolic Disorders
4. Reduced Renal α-Klotho Expression in CKD Patients and Its Effect on Renal Phosphate Handling and Vitamin D Metabolism
   Hirokazu Sakan, Kimihiko Nakatani, Osamu Asai, Akihiro Imura, Tomohiro Tanaka, Shuhei Yoshimoto, Noriyuki Iwamoto, Norio Kurumatani, Masayuki Iwano, Yo‐ichi Nabeshima et al. · 2014 · PLoS ONE
5. Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders
   Marc G. Vervloet, Ziad A. Massy, Vincent Matthias Brandenburg, Sandro Mazzaferro, Mario Gennaro Cozzolino, Pablo Ureña, Jordi Bover, David J.A. Goldsmith · 2014 · The Lancet Diabetes & Endocrinology
6. Novel targets of antifibrotic and anti-inflammatory treatment in CKD
   Anne‐Émilie Declèves, Kumar Sharma · 2014 · Nature Reviews Nephrology
7. Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community
   Johan Ärnlöv, Axel Carl Carlsson, Johan Sundström, Erik Ingelsson, Anders Olof Larsson, Lars Lind, Tobias E. Larsson · 2012 · Kidney International
8. Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease
   Natalia Carrillo‐López, Sara Panizo, Cristina Alonso‐Montes, Pablo Román‐García, Isabel Rodrı́guez, Carlos Martínez‐Salgado, Adriana Dusso, Manuel Naves‐Díaz, Jorge Benito Cannata-Andía · 2016 · Kidney International
9. A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation
   Myles Selig Wolf, Matthew R. Weir, Nelson P. Kopyt, Roslyn Bernstein Mannon, Jon R. Von Visger, Hongjie Deng, Susan V. Yue, Flavio G. Vincenti · 2015 · Transplantation
10. Fibroblast Growth Factor-23 and Incident Atrial Fibrillation: The Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS)
    Mathew, Jehu S., Sachs, Michael C., Katz, Ronit, Patton, Kristen K., Heckbert, Susan R., Hoofnagle, Andrew N., Alonso, Alvaro, Chonchol, Michel, Deo, Rajat, Ix, Joachim H. et al. · 2014 · Circulation
11. A 12-Week, Double-Blind, Placebo-Controlled Trial of Ferric Citrate for the Treatment of Iron Deficiency Anemia and Reduction of Serum Phosphate in Patients With CKD Stages 3-5
    Geoffrey A. Block, Steven N. Fishbane, Mariano Rodríguez, Gerard Smits, Shay Shemesh, Pablo E. Pérgola, Myles Selig Wolf, Glenn Matthew Chertow · 2014 · American Journal of Kidney Diseases
12. FGF-23 Is a Negative Regulator of Prenatal and Postnatal Erythropoiesis
    Lindsay M. Coe, Sangeetha Vadakke Madathil, Carla Casu, Beate Lanske, Stefano Rivella, Despina Sitara · 2014 · Journal of Biological Chemistry
13. Interpreting Cardiac Troponin Results from High-Sensitivity Assays in Chronic Kidney Disease without Acute Coronary Syndrome
    Christopher R. deFilippi, Stephen L. Seliger, Walter E. Kelley, Show‐Hong Duh, Michael K. Hise, Robert H. Christenson, Myles Selig Wolf, Hanna Kim Gaggin, James L. Januzzi · 2012 · Clinical Chemistry
14. Pharmacological inhibition of fibroblast growth factor (FGF) receptor signaling ameliorates FGF23-mediated hypophosphatemic rickets
    Simon Wöhrle, Christine Henninger, Olivier Bonny, Anne Thuery, Noémie Beluch, Nancy E. Hynes, Vito Guagnano, William R. Sellers, Francesco Hofmann, Michaela Kneissel et al. · 2012 · Journal of Bone and Mineral Research
15. Roles of FGF Signals in Heart Development, Health, and Disease
    Nobuyuki Itoh, Hiroya Ohta, Yoshiaki Nakayama, Morichika Konishi · 2016 · Frontiers in Cell and Developmental Biology
16. Klotho protects the heart from hyperglycemia-induced injury by inactivating ROS and NF-κB-mediated inflammation both in vitro and in vivo
    Yue Guo, Xiaodong Zhuang, Zena Huang, Jing Zou, Da-Ya David Yang, Xun Hu, Zhimin Du, Lichun Wang, Xinxue Liao · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
17. Renal and extrarenal effects of fibroblast growth factor 23
    Marc G. Vervloet · 2018 · Nature Reviews Nephrology
18. The basics of phosphate metabolism
    Carsten Alexander Wagner · 2023 · Nephrology Dialysis Transplantation
19. Arterial disease in chronic kidney disease
    William Edward Moody, Nicola C. Edwards, Colin Dominic Chue, Charles Joseph Ferro, John Townend · 2012 · Heart
20. Phosphate Toxicity in CKD: The Killer among Us
    Cynthia S. Ritter, Eduardo Slatopolsky · 2016 · Clinical Journal of the American Society of Nephrology
21. Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice
    Wenchao Zhang, Aika Miikeda, Jonathan E. Zuckerman, Xun Jia, Sarada Charugundla, Zhiqiang Zhou, Karolina Elżbieta Kaczor‐Urbanowicz, Clara E. Magyar, Fangfei Guo, Zeneng Wang et al. · 2021 · Scientific Reports
22. Effects of Dietary Phosphate Restriction and Phosphate Binders on FGF23 Levels in CKD
    Tamara Isakova, Allison Barchi-Chung, Gwen Enfield, Kelsey T. Smith, Gabriella Vargas, Jessica Houston, Huiliang Xie, PATRICIA W. WAHL, Eva Schiavenato, Austin R. Dosch et al. · 2013 · Clinical Journal of the American Society of Nephrology
23. Cardiac Remodeling in Chronic Kidney Disease
    Nadine Kaesler, Anne Babler, Jürgen Floege, Rafael Kramann · 2020 · Toxins
24. Fibroblast Growth Factor-23 and Cardiovascular Disease in the General Population
    Bryan R. Kestenbaum, Michael Charles Sachs, Andy N. Hoofnagle, David S. Siscovick, Joachim H. Ix, Cassianne Robinson‐Cohen, João A.C. Lima, Joseph F. Polak, Marc Blondon, JOHN T. RUZINSKI et al. · 2014 · Circulation Heart Failure
25. X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment
    Yuka Kinoshita, Seiji Fukumoto · 2018 · Endocrine Reviews
26. Associations of FGF-23 and sKlotho with Cardiovascular Outcomes among Patients with CKD Stages 2–4
    Sarah Seiler, Kyrill Sebastian Rogacev, Heinz Jürgen Roth, Pagah Shafein, Insa E. Emrich, Stefan Neuhaus, Jürgen Floege, Danilo Fliser, Gunnar Henrik Heine · 2014 · Clinical Journal of the American Society of Nephrology
27. New developments in the biology of fibroblast growth factors
    David M. Ornitz, Nobuyuki Itoh · 2022 · WIREs Mechanisms of Disease
28. Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC)
    The CRIC Study Investigators, Ruth F. Dubin, Yongmei Li, Jiang He, Bernard G. Jaar, Radhakrishna Reddy Kallem, James Phillip Lash, Gail K. Makos, Sylvia E. Rosas, Elsayed Z. Soliman et al. · 2013 · BMC Nephrology
29. Plasma Klotho is not related to kidney function and does not predict adverse outcome in patients with chronic kidney disease
    Sarah Seiler, Ming Wen, Heinz Jürgen Roth, Michael Fehrenz, Franziska Flügge, Esther Herath, Anja Weihrauch, Danilo Fliser, Gunnar Henrik Heine · 2012 · Kidney International
30. The emerging role of Klotho in clinical nephrology
    Ming Chang Hu, Makoto Kuro‐o, Orson W. Moe · 2012 · Nephrology Dialysis Transplantation
31. Low Vitamin D and High Fibroblast Growth Factor 23 Serum Levels Associate with Infectious and Cardiac Deaths in the HEMO Study
    Michel Chonchol, Tom Greene, Yingying Zhang, Andrew N. Hoofnagle, Alfred K. Cheung · 2015 · Journal of the American Society of Nephrology
32. Arterial Klotho Expression and FGF23 Effects on Vascular Calcification and Function
    Karolina Lindberg, Hannes Olauson, Risul Amin, Arvind Ponnusamy, Regina M. Goetz, Rebecca F. Taylor, Moosa Mohammadi, Ann E. Canfield, Karolina R. Kublickiene, Tobias E. Larsson · 2013 · PLoS ONE
33. Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation
    Winnie Chua, Yanish Purmah, Victor Roth Cardoso, Georgios V. Gkoutos, Samantha P. Tull, Georgiana Neculau, Mark Roland Thomas, Dipak Kotecha, Gregory Y.H. Lip, Paulus F. Kirchhof et al. · 2018 · European Heart Journal
34. Uremic Toxins: An Alarming Danger Concerning the Cardiovascular System
    Carlos Alexandre Falconi, Carolina Victória Cruz Junho, Fernanda Fogaça-Ruiz, Imara Caridad Stable Vernier, Regiane Stafim da Cunha, Andréa Emília Marques Stinghen, Marcela Sorelli Carneiro‐Ramos · 2021 · Frontiers in Physiology
35. Regulation of renal phosphate transport by FGF23 is mediated by FGFR1 and FGFR4.
    J. Gattineni, P. Alphonse, Qiuyu Zhang, N. Mathews, C. Bates, M. Baum · 2014 · AJP - Renal Physiology
36. Effects of Klotho on fibrosis and cancer: A renal focus on mechanisms and therapeutic strategies
    Rik Mencke, Hannes Olauson, Jan‐Luuk Hillebrands · 2017 · Advanced Drug Delivery Reviews
37. The FGF metabolic axis
    Xiaokun Li · 2019 · Frontiers of Medicine
38. Phosphate—a poison for humans?
    Hirotaka Komaba, Masafumi Fukagawa · 2016 · Kidney International
39. FGF23/FGFR4-mediated left ventricular hypertrophy is reversible
    Alexander Grabner, Karla J. Schramm, Neerupma Silswal, Matt Hendrix, Christopher Yanucil, Brian A. Czaya, Saurav Singh, Myles Selig Wolf, Sven Hermann, Jörg Stypmann et al. · 2017 · Scientific Reports
40. FGF23 and klotho at the intersection of kidney and cardiovascular disease
    Daniel L. Edmonston, Alexander Grabner, Myles Selig Wolf · 2023 · Nature Reviews Cardiology
41. Direct, Acute Effects of Klotho and FGF23 on Vascular Smooth Muscle and Endothelium
    Isabelle Six, Hirokazu Okazaki, Priscilla Gross, Joanna Cagnard, Cédric Boudot, Julien Maizel, Tilman Bernhard Drüeke, Ziad A. Massy · 2014 · PLoS ONE
42. Effects of Cinacalcet on Atherosclerotic and Nonatherosclerotic Cardiovascular Events in Patients Receiving Hemodialysis: The EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial
    David Collins. Wheeler, Gerard Michel London, Patrick S. Parfrey, Geoffrey A. Block, Ricardo Correa‐Rotter, Bastian Dehmel, Tilman Bernhard Drüeke, Jürgen Floege, Yumi Kubo, Kenneth W. Mahaffey et al. · 2014 · Journal of the American Heart Association
43. Longitudinal FGF23 Trajectories and Mortality in Patients with CKD
    Tamara Isakova, Xuan Cai, Jungwha Julia Lee, Dawei Xie, Xue Wang, Rupal C. Mehta, Norrina B. Allen, Julia J. Scialla, Michael J. Pencina, Amanda Hyre Anderson et al. · 2017 · Journal of the American Society of Nephrology
44. Chronic Renal Insufficiency Cohort Study (CRIC)
    Matthew G. Denker, Suzanne Boyle, Amanda Hyre Anderson, Lawrence J. Appel, Jing Chen, Jeffrey Craig Fink, John M. Flack, Alan S. Go, Edward J. Horwitz, Chi‐yuan Hsu et al. · 2015 · Clinical Journal of the American Society of Nephrology
45. Re‐evaluation of phosphoric acid–phosphates – di‐, tri‐ and polyphosphates (E 338–341, E 343, E 450–452) as food additives and the safety of proposed extension of use
    EFSA Panel on Food Additives and Flavourings (FAF), Maged Younes, Gabriele Aquilina, Laurence Castle, Karl‐Heinz Engel, Paul Fowler, María José Frutos Fernández, Peter Fürst, Rainer Gürtler, Trine Husøy et al. · 2019 · EFSA Journal
46. Fibroblast Growth Factor‐23 and Incident Coronary Heart Disease, Heart Failure, and Cardiovascular Mortality: The Atherosclerosis Risk In Communities Study
    Pamela L. Lutsey, Álvaro Alonso, Elizabeth Selvin, James S. Pankow, Erin D. Michos, Sunil Kumar Agarwal, Laura R. Loehr, John H. Eckfeldt, Josef Coresh · 2014 · Journal of the American Heart Association
47. Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD
    Tamara Isakova, Joachim H. Ix, Stuart Michael Sprague, Kalani L. Raphael, Linda P. Fried, Jennifer Gassman, Dominic S. Raj, Alfred K. Cheung, John W. Kusek, Michael F. Flessner et al. · 2015 · Journal of the American Society of Nephrology
48. Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease
    Jair Munoz Mendoza, Tamara Isakova, Xuan Cai, Liz Y. Bayes, Christian Faul, Julia J. Scialla, James Phillip Lash, Jing Chen, Jiang He, Sankar Dass Navaneethan et al. · 2016 · Kidney International
49. The Role of the Osteocyte in Bone and Nonbone Disease
    Lynda Faye Bonewald · 2016 · Endocrinology and Metabolism Clinics of North America
50. Aging-suppressor Klotho: Prospects in diagnostics and therapeutics
    Carmela R. Abraham, Anne Li · 2022 · Ageing Research Reviews
51. Fibroblast growth factor 23: state of the field and future directions
    Nisan Bhattacharyya, William H Chong, Rachel Ilana Gafni, Michael Terrence Collins · 2012 · Trends in Endocrinology and Metabolism
52. FGF23 production by osteocytes
    Lynda Faye Bonewald, Michael Wacker · 2012 · Pediatric Nephrology
53. The osteocyte plays multiple roles in bone remodeling and mineral homeostasis
    Huayue Chen, Takao Senda, Kin‐ya Kubo · 2015 · Medical Molecular Morphology
54. FGF-23 and secondary hyperparathyroidism in chronic kidney disease
    Justin Silver, Tally Naveh‐Many · 2013 · Nature Reviews Nephrology
55. Cardiovascular Effects of Sevelamer in Stage 3 CKD
    Colin Dominic Chue, John Townend, William Edward Moody, Daniel Zehnder, Nadezhda A. Wall, Lorraine Harper, Nicola C. Edwards, Richard Paul Steeds, Charles Joseph Ferro · 2013 · Journal of the American Society of Nephrology
56. Klotho expression in osteocytes regulates bone metabolism and controls bone formation
    Hirotaka Komaba, Jovana Kaludjerovic, Dorothy Zhang Hu, Kenichi Nagano, Katsuhiko Amano, Noriko Ide, Tadatoshi Sato, Michael Densmore, Jun-ichi Hanai, Hannes Olauson et al. · 2017 · Kidney International
57. Strategies for Phosphate Control in Patients With CKD
    Fellype Carvalho Barreto, Daniela Veit Barreto, Ziad A. Massy, Tilman Bernhard Drüeke · 2019 · Kidney International Reports
58. Regulation and Effects of FGF23 in Chronic Kidney Disease
    John Musgrove, Myles Selig Wolf · 2019 · Annual Review of Physiology
59. Novel biological markers of bone: from bone metabolism to bone physiology
    Roland D Chapurlat, Cyrille B. Confavreux · 2016 · Rheumatology
60. Glycerol-3-phosphate is an FGF23 regulator derived from the injured kidney
    Petra Šimić, Wondong Kim, Wen Zhou, Kerry A. Pierce, Wenhan Chang, David B. Sykes, Najihah Aziz, Sammy Elmariah, Debby Ngo, Paola Divieti Pajevic et al. · 2020 · Journal of Clinical Investigation
61. Counter‐regulatory paracrine actions of FGF ‐23 and 1,25( OH ) 2 D in macrophages
    Xiaobin Han, Linqiang Li, Jiancheng Yang, Gwendalyn D. King, Zhousheng Xiao, L. Darryl Quarles · 2015 · FEBS Letters
62. FGF23 promotes myocardial fibrosis in mice through activation of β-catenin
    Huixin Hao, Xixian Li, Qingman Li, Hairuo Lin, Zhenhuan Chen, Jiahe Xie, Wanling Xuan, Wangjun Liao, Jianping Bin, Xiaobo Huang et al. · 2016 · Oncotarget
63. Vitamin D, a modulator of musculoskeletal health in chronic kidney disease
    Pablo Molina, Juan Jesús Carrero, Jordi Bover, Philippe Chauveau, Sandro Mazzaferro, Pablo Ureña · 2017 · Journal of Cachexia Sarcopenia and Muscle
64. The Mechanosensory Role of Osteocytes and Implications for Bone Health and Disease States
    Jung Un Ally Choi, Amanda Wraith Kijas, Ján Lauko, Alan E. Rowan · 2022 · Frontiers in Cell and Developmental Biology
65. Erythropoietin stimulates murine and human fibroblast growth factor-23, revealing novel roles for bone and bone marrow
    Erica L. Clinkenbeard, Mark R. Hanudel, Keith R. Stayrook, Hitesh Nidumanda Appaiah, Emily Farrow, Taryn A. Cass, Lelia J. Summers, Colin S. Ip, Julia M. Hum, Joseph C. Thomas et al. · 2017 · Haematologica
66. Insulin suppresses the production of fibroblast growth factor 23 (FGF23)
    Ludmilla Bär, Martina Feger, Abul Fajol, Lars‐Oliver Klotz, Shufei Zeng, Florian J.W. Lang, Berthold Hocher, Michael Föller · 2018 · Proceedings of the National Academy of Sciences
67. Cardiorenal Syndrome
    Claudio Ronco, Luca Di Lullo · 2014 · Heart Failure Clinics
68. Muscle–Bone Crosstalk: Emerging Opportunities for Novel Therapeutic Approaches to Treat Musculoskeletal Pathologies
    Delphine B. Maurel, Katharina Jähn, Nuria Lara-Castillo · 2017 · Biomedicines
69. Tumor-induced Osteomalacia: A Comprehensive Review
    Salvatore Minisola, Seiji Fukumoto, Weibo Xia, Alessandro Corsi, Luciano Colangelo, Alfredo Scillitani, Jessica Pepe, Cristiana Cipriani, Rajesh V. Thakker · 2022 · Endocrine Reviews
70. Pathophysiological roles of FGF signaling in the heart
    Nobuyuki Itoh, Hiroya Ohta · 2013 · Frontiers in Physiology
71. Effects of Ferric Citrate in Patients with Nondialysis-Dependent CKD and Iron Deficiency Anemia
    Steven N. Fishbane, Geoffrey A. Block, Lisa Carole Loram, John F. Neylan, Pablo E. Pérgola, Katrin Uhlig, Glenn Matthew Chertow · 2017 · Journal of the American Society of Nephrology
72. Update on FGF23 and Klotho signaling
    Reinhold G. Erben · 2016 · Molecular and Cellular Endocrinology
73. Endocrine Crosstalk Between Muscle and Bone
    Marco A. P. Brotto, Mark L. Johnson · 2014 · Current Osteoporosis Reports
74. Tissue expression and source of circulating αKlotho
    Hannes Olauson, Rik Mencke, Jan‐Luuk Hillebrands, Tobias E. Larsson · 2017 · Bone
75. Exploring the Clinical Relevance of Providing Increased Removal of Large Middle Molecules
    Martin J. Wolley, Meg Jardine, Colin A. Hutchison · 2018 · Clinical Journal of the American Society of Nephrology
76. Speckle Tracking Echocardiography Detects Uremic Cardiomyopathy Early and Predicts Cardiovascular Mortality in ESRD
    Rafael Kramann, Johanna Erpenbeck, Rebekka K. Schneider, Anna Bettina Röhl, Marc Hein, Vincent Matthias Brandenburg, Merel van Diepen, Friedo Wilhelm Dekker, Nicolaus Marx, Jürgen Floege et al. · 2014 · Journal of the American Society of Nephrology
77. Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia
    Rafiou Agoro, Anna Montagna, Regina M. Goetz, Onyedikachi Aligbe, Gurinder K. Singh, Lindsay M. Coe, Moosa Mohammadi, Stefano Rivella, Despina Sitara · 2018 · The FASEB Journal
78. The effect of vitamin D status on risk factors for cardiovascular disease
    Sujana S. Gunta, Ravi Thadhani, ROBERT H. K. MAK · 2013 · Nature Reviews Nephrology
79. Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21
    Eleni M. Domouzoglou, Katerina Κ. Naka, Antonios P. Vlahos, Michail I. Papafaklis, Lampros K. Michalis, Agathoklis Tsatsoulis, Eleftheria Maratos–Flier · 2015 · American Journal of Physiology-Heart and Circulatory Physiology
80. Fibroblast Growth Factor 23 and Cardiovascular Mortality after Kidney Transplantation
    Leandro C. Baia, Jelmer K. Humalda, Marc G. Vervloet, Gerjan J Navis, Stephan J. L. Bakker, Martin H. de Borst · 2013 · Clinical Journal of the American Society of Nephrology
81. Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome
    Suree Lekawanvijit · 2018 · Toxins
82. The role of epigenetics in renal ageing
    Shiels, Paul G., McGuinness, Dagmara, Eriksson, Maria, Kooman, Jeroen P., Stenvinkel, Peter · 2017 · Nature Reviews Nephrology
83. Calcitriol, calcidiol, parathyroid hormone, and fibroblast growth factor‐23 interactions in chronic kidney disease
    Joao Felipe de Brito Galvão, Larry Allen Nagode, Patricia A. Schenck, Dennis J. Chew · 2013 · Journal of Veterinary Emergency and Critical Care
84. Serum FGF23 and Risk of Cardiovascular Events in Relation to Mineral Metabolism and Cardiovascular Pathology
    Johan Ärnlöv, Axel Carl Carlsson, Johan Sundström, Erik Ingelsson, Anders Olof Larsson, Lars Lind, Tobias E. Larsson · 2013 · Clinical Journal of the American Society of Nephrology
85. Fibroblast growth factor-23: what we know, what we don't know, and what we need to know
    Csaba Pal Kovesdy, L. Darryl Quarles · 2013 · Nephrology Dialysis Transplantation
86. Gastrointestinal Inhibition of Sodium-Hydrogen Exchanger 3 Reduces Phosphorus Absorption and Protects against Vascular Calcification in CKD
    Eric D. Labonté, Christopher W. Carreras, Michael R. Leadbetter, Kenji Kozuka, Jill N. Kohler, Samantha Koo-McCoy, Limin He, Edward E. Dy, Deborah Black, Ziyang Zhong et al. · 2014 · Journal of the American Society of Nephrology
87. Pediatric Cardiomyopathies: causes, epidemiology, Clinical course, Preventive Strategies and Therapies
    Steven E. Lipshultz, Thomas R. Cochran, David A. Briston, Stefanie R. Brown, Peter Sambatakos, Tracie L. Miller, Adriana A. Carrillo, Liat Corcia, Janine E. Sanchez, Melissa B. Diamond et al. · 2013 · Future Cardiology
88. Ironing out the cross talk between FGF23 and inflammation
    Valentin David, Connor P. Francis, Jodie L. Babitt · 2016 · American Journal of Physiology-Renal Physiology
89. Dietary phosphorus is associated with greater left ventricular mass
    Kalani T. Yamamoto, Cassianne Robinson‐Cohen, Marcia C. de Oliveira, А. N. Kostina, Jennifer A. Nettleton, Joachim H. Ix, Ha Nguyen, John Eng, João A.C. Lima, David S. Siscovick et al. · 2013 · Kidney International
90. Inflammation regulates fibroblast growth factor 23 production
    Connor P. Francis, Valentin David · 2016 · Current Opinion in Nephrology & Hypertension
91. Fibroblast growth factor 23 and Klotho contribute to airway inflammation
    Stefanie Krick, Alexander Grabner, Nathalie Baumlin, Christopher Yanucil, Scott Helton, Astrid Grosche, Juliette Sailland, Patrick M. Geraghty, Liliana Viera, Derek W. Russell et al. · 2018 · European Respiratory Journal
92. Paracrine Effects of FGF23 on the Heart
    Maren Leifheit‐Nestler, Dieter Haffner · 2018 · Frontiers in Endocrinology
93. Role of Chronic Kidney Disease (CKD)–Mineral and Bone Disorder (MBD) in the Pathogenesis of Cardiovascular Disease in CKD
    Shunsuke Yamada, Toshiaki Nakano · 2023 · Journal of Atherosclerosis and Thrombosis
94. Mineral Metabolites and CKD Progression in African Americans
    Julia J. Scialla, Brad C. Astor, Tamara Isakova, Huiliang Xie, Lawrence J. Appel, Myles Selig Wolf · 2012 · Journal of the American Society of Nephrology
95. Klotho modulates FGF23-mediated NO synthesis and oxidative stress in human coronary artery endothelial cells
    Beatrice Richter, Jacqueline Haller, Dieter Haffner, Maren Leifheit‐Nestler · 2016 · Pflügers Archiv - European Journal of Physiology
96. Novel metabolic biomarkers of cardiovascular disease
    Majken K. Jensen, Monica L. Bertoia, Leah E. Cahill, Isha Agarwal, Eric B. Rimm, Kenneth Jay Mukamal · 2014 · Nature Reviews Endocrinology
97. Impact of Vitamin D Supplementation on Arterial Vasomotion, Stiffness and Endothelial Biomarkers in Chronic Kidney Disease Patients
    Nihil Chitalia, Tuan Salwani Tuan Ismail, Laura Tooth, Frances G. Boa, Geeta Hampson, David J.A. Goldsmith, Juan Carlos Kaski, Debasish Banerjee · 2014 · PLoS ONE
98. Vitamin D and chronic kidney disease
    Chang Seong Kim, Soo Wan Kim · 2014 · The Korean Journal of Internal Medicine
99. A phosphate-centric paradigm for pathophysiology and therapy of chronic kidney disease
    Makoto Kuro‐o · 2013 · Kidney International Supplements
100. Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study
     Rupal C. Mehta, Xuan Cai, Jungwha Julia Lee, Julia J. Scialla, Nisha Bansal, James Sondheimer, Jing Chen, Lotuce Lee Hamm, Ana Catherine Ricardo, Sankar Dass Navaneethan et al. · 2016 · JAMA Cardiology